Archives of Neuroscience

Published by: Kowsar

Neuroprotective Treatment With FK506 Reduces Hippocampal Damage and Prevents Learning and Memory Deficits After Transient Global Ischemia in Rat

Zahra Nadia Sharifi 1 , Farid Abolhassani 2 , Gholamreza Hassanzadeh 2 , Mohammad Reza Zarrindast 3 and Shabnam Movassaghi 1 , *
Authors Information
1 Anatomy Department, School of Medicine, Tehran Medical Branch, Islamic Azad University, Tehran, Iran
2 Anatomy Department, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
3 Pharmacology Department, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
Article information
  • Archives of Neuroscience: April 01, 2014, 1 (1); 35-40
  • Published Online: April 1, 2014
  • Article Type: Research Article
  • Received: March 19, 2012
  • Revised: May 13, 2013
  • Accepted: May 14, 2013
  • DOI: 10.5812/archneurosci.9163

To Cite: Nadia Sharifi Z, Abolhassani F, Hassanzadeh G, Zarrindast M R, Movassaghi S. Neuroprotective Treatment With FK506 Reduces Hippocampal Damage and Prevents Learning and Memory Deficits After Transient Global Ischemia in Rat, Arch Neurosci. 2014 ; 1(1):35-40. doi: 10.5812/archneurosci.9163.

Abstract
Copyright © 2014, Tehran University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
6. Conclusions
Acknowledgements
Footnotes
References
  • 1. Green EJ, Dietrich WD, van Dijk F, Busto R, Markgraf CG, McCabe PM, et al. Protective effects of brain hypothermia on behavior and histopathology following global cerebral ischemia in rats. Brain Res. 1992; 580(1-2): 197-204[PubMed]
  • 2. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res. 1982; 239(1): 57-69[PubMed]
  • 3. Pulsinelli WA, Brierley JB, Plum F. Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann Neurol. 1982; 11(5): 491-8[DOI][PubMed]
  • 4. Yakovlev AG, Knoblach SM, Fan L, Fox GB, Goodnight R, Faden AI. Activation of CPP32-like caspases contributes to neuronal apoptosis and neurological dysfunction after traumatic brain injury. J Neurosci. 1997; 17(19): 7415-24[PubMed]
  • 5. Namura S, Zhu J, Fink K, Endres M, Srinivasan A, Tomaselli KJ, et al. Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia. J Neurosci. 1998; 18(10): 3659-68[PubMed]
  • 6. Grotta J. The current status of neuronal protective therapy: why have all neuronal protective drugs worked in animals but none so far in stroke patients? Cerebrovasc Dis. 1994; 4: 115-120
  • 7. Neuroprotection as initial therapy in acute stroke. Third Report of an Ad Hoc Consensus Group Meeting. The European Ad Hoc Consensus Group. Cerebrovasc Dis. 1998; 8(1): 59-72[PubMed]
  • 8. Sharkey J, Butcher SP. Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia. Nature. 1994; 371(6495): 336-9[DOI][PubMed]
  • 9. Butcher SP, Henshall DC, Teramura Y, Iwasaki K, Sharkey J. Neuroprotective actions of FK506 in experimental stroke: in vivo evidence against an antiexcitotoxic mechanism. J Neurosci. 1997; 17(18): 6939-46[PubMed]
  • 10. Arii T, Kamiya T, Arii K, Ueda M, Nito C, Katsura KI, et al. Neuroprotective effect of immunosuppressant FK506 in transient focal ischemia in rat: therapeutic time window for FK506 in transient focal ischemia. Neurol Res. 2001; 23(7): 755-60[PubMed]
  • 11. Tokime T, Nozaki K, Kikuchi H. Neuroprotective effect of FK506, an immunosuppressant, on transient global ischemia in gerbil. Neurosci Lett. 1996; 206(2-3): 81-4[PubMed]
  • 12. Yagita Y, Kitagawa K, Matsushita K, Taguchi A, Mabuchi T, Ohtsuki T, et al. Effect of immunosuppressant FK506 on ischemia-induced degeneration of hippocampal neurons in gerbils. Life Sci. 1996; 59(19): 1643-50[PubMed]
  • 13. Drake M, Friberg H, Boris-Moller F, Sakata K, Wieloch T. The immunosuppressant FK506 ameliorates ischaemic damage in the rat brain. Acta Physiol Scand. 1996; 158(2): 155-9[PubMed]
  • 14. Steiner JP, Hamilton GS, Ross DT, Valentine HL, Guo H, Connolly MA, et al. Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models. Proc Natl Acad Sci JSA. 1997; 94(5): 2019-24[PubMed]
  • 15. Hernandez-Espinosa D, Morton AJ. Calcineurin inhibitors cause an acceleration of the neurological phenotype in a mouse transgenic for the human Huntington's disease mutation. Brain Res Bull. 2006; 69(6): 669-79[DOI][PubMed]
  • 16. Klettner A, Baumgrass R, Zhang Y, Fischer G, Burger E, Herdegen T, et al. The neuroprotective actions of FK506 binding protein ligands: neuronal survival is triggered by de novo RNA synthesis, but is independent of inhibition of JNK and calcineurin. Mol Brain Res. 97: 21–31
  • 17. Morioka M, Fukunaga K, Kai Y, Todaka T, Yano S, Hamada J, et al. Intravenously injected FK506 failed to inhibit hippocampal calcineurin. Biochem Biophys Res Commun. 2001; 286(4): 802-6[DOI][PubMed]
  • 18. Morris RG, Garrud P, Rawlins JN, O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature. 1982; 297(5868): 681-3[PubMed]
  • 19. Sharkey J, Crawford JH, Butcher SP, Marston HM. Tacrolimus (FK506) ameliorates skilled motor deficits produced by middle cerebral artery occlusion in rats. Stroke. 1996; 27(12): 2282-6[PubMed]
  • 20. Tanaka K, Hori K, Wada-Tanaka N, Nomura M, Ogawa N. FK506 ameliorates the discrimination learning impairment due to preventing the rarefaction of white matter induced by chronic cerebral hypoperfusion in rats. Brain Res. 2001; 906(1-2): 184-9[PubMed]
  • 21. Peeling J, Yan HJ, Corbett D, Xue M, Del Bigio MR. Effect of FK-506 on inflammation and behavioral outcome following intracerebral hemorrhage in rat. Exp Neurol. 2001; 167(2): 341-7[DOI][PubMed]
  • 22. Gabryel B, Chalimoniuk M, Stolecka A, Waniek K, Langfort J, Malecki A. Inhibition of arachidonic acid release by cytosolic phospholipase A2 is involved in the antiapoptotic effect of FK506 and cyclosporin a on astrocytes exposed to simulated ischemia in vitro. J Pharmacol Sci. 2006; 102(1): 77-87[PubMed]
  • 23. Maeda M, Furuichi Y, Noto T, Matsuoka N, Mutoh S, Yoneda Y. Tacrolimus (FK506) suppresses rt-PA-induced hemorrhagic transformation in a rat thrombotic ischemia stroke model. Brain Res. 2009; 1254: 99-108[DOI][PubMed]
  • 24. Benetoli A, Dutra AM, Paganelli RA, Senda DM, Franzin S, Milani H. Tacrolimus (FK506) reduces hippocampal damage but fails to prevent learning and memory deficits after transient, global cerebral ischemia in rats. Pharmacol Biochem Behav. 2007; 88(1): 28-38[DOI][PubMed]
  • 25. Furuichi Y, Katsuta K, Maeda M, Ueyama N, Moriguchi A, Matsuoka N, et al. Neuroprotective action of tacrolimus (FK506) in focal and global cerebral ischemia in rodents: dose dependency, therapeutic time window and long-term efficacy. Brain Res. 2003; 965(1-2): 137-45[PubMed]
  • 26. Ide T, Morikawa E, Kirino T. An immunosuppressant, FK506, protects hippocampal neurons from forebrain ischemia in the mongolian gerbil. Neurosci Lett. 1996; 204(3): 157-60[PubMed]
  • 27. Giordani A, Benetolli LA, Favero-Filho KCM, Lima L, Cestari Junior H, Milani F. Tacrolimus (FK506) reduces ischemia-induced hippocampal damage in rats: a 7- and 30-day study. Braz J Med Biol Res. 1996; 36: 495-502
  • 28. Bachevalier J, Meunier M. Cerebral ischemia: are the memory deficits associated with hippocampal cell loss? Hippocampus. 1999; 66: 553-60
  • 29. Rod MR, Whishaw IQ, Auer RN. The relationship of structural ischemic brain damage to neurobehavioural deficit: the effect of postischemic MK-801. Can J Psychol. 1990; 44(2): 196-209[PubMed]
  • 30. Kiyota Y, Miyamoto M, Nagaoka A. Relationship between brain damage and memory impairment in rats exposed to transient forebrain ischemia. Brain Res. 1991; 538(2): 295-302[PubMed]
  • 31. Milani H, Uemura UU, Oliveira RM, Lepri ER, Xavier GF. Loss of CA1 cells following global ischaemia correlates with spatial deficits in the circular platform task. J Neurosci Methods. 1998; 80(1): 19-27[PubMed]
  • 32. Hodges H, Nelson A, Virley D, Kershaw TR, Sinden JD. Cognitive deficits induced by global cerebral ischaemia: prospects for transplant therapy. Pharmacol Biochem Behav. 1997; 56(4): 763-80[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments